Press releases and News
2023-02-09 10:15
The TetraSens® Pediatric sensor has received regulatory approval in Japan, further supporting the roll out of Senzime’s innovative patient monitoring systems Uppsala, February 9, 2023. Senzime AB (publ) today announced that the TetraGraph®...
2023-01-26 14:30
Senzime invites investors, analysts, and media to a presentation of the interim report for the fourth quarter 2022 on February 1, 14:00 CET. The report will be published at 8:30 CET the same day. During the presentation, Senzime’s CEO Pia Renaudin...
2022-12-16 10:40
Uppsala, December 16, 2022. Senzime AB (publ) announced today that the American Society of Anesthesiologists (ASA) has now published the clinical guidelines for monitoring and reversal of neuromuscular blockade. This is the first time that ASA recommends...
2022-12-07 12:15
Uppsala, December 7, 2022. Senzime AB (publ) today announced that the company has received its first dedicated TetraSens® Pediatric contract from a leading university hospital, ranked among the best hospitals nationally in the US. The TetraSens Pediatric...
2022-11-16 09:05
The European Society of Anaesthesiology and Intensive Care (ESAIC) strongly recommends the use of quantitative neuromuscular monitoring to prevent complications related to muscle relaxants. Senzime’s TetraGraph® system fulfills these new guidelines...
2022-11-10 14:30
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, at 13:00-15:00 CET. Pia Renaudin, CEO, will together with Kay Krüger (Business manager ExSpiron products) and Sorin J. Brull (Professor...
2022-10-27 10:00
Uppsala, October 27, 2022. Senzime AB (publ) today announced that the American Society of Anesthesiologists (ASA) has voted on final approval of clinical guidelines for monitoring and reversal of neuromuscular blockade. This is the first time that ASA...
2022-10-25 10:00
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, in the afternoon. The purpose is to give an update of the strategy following the acquisition of Respiratory Motion, describe the market...
2022-09-07 11:50
Uppsala, Sweden. September 7, 2022: Senzime today announced that a study published ahead of print in the Saudi Journal of Anesthesia concludes that TetraGraph, the company’s electromyography (EMG)-based monitor, is effective for monitoring neuromuscular...
2022-08-05 08:30
News: Uppsala, August 5, 2022. Senzime announces today the launch of TetraGraph® Xcom, a solution that enables communication between the TetraGraph® and Philips Capsule Medical Device Information Platform (MDIP). The integration enables the electronic...
